You are here: Industry Insights > COVID-19

News List

Premas Biotech announces completion of vaccine prototype of triple-antigen candidate against COVID-1 expresspharma
May 20, 2020
Reportedly, the vaccine prototype is among the first in the world for VLP of SARS CoV-2 virus.
COVID-19 has made effective use of data in clinical development even more critical expresspharma
May 20, 2020
Parexel has deployed at-home care and monitoring as well as delivered supplies and drug products Direct-to-Patient to minimise the impact of the Covid-19 pandemic on ongoing clinical trials, says Sanjay Vyas, Parexel’s Senior Vice President ...
ERT launches Virtual Visit solutions to keep clinical trials on track during COVID-19 expresspharma
May 20, 2020
The company's seamless, dynamic solution enables continued interactions between clinical trial patients and investigative sites.
Ashwagandha can be effective preventive drug against coronavirus: IIT Delhi research expresspharma
May 19, 2020
The Indian government has also initiated a study on whether Ashwagandha can be an alternative to hydroxychloroquine as a potential COVID-19 preventive.
New COVID-19 guidelines for CKD and interstitial lung disease pharmatimes
May 19, 2020
The National Institute for Health and Care Excellence has published two new rapid COVID-19 guidelines for chronic kidney disease (CKD) and interstitial lung disease.
Phase IIb trial to study hydroxychloroquine and azithromycin as COVID-19 treatment launched europeanpharmaceuticalreview
May 19, 2020
A double-blind clinical trial has begun in the US to study hydroxychloroquine and azithromycin treatment in patients with COVID-19.
Sorrento’s antibody completely blocks Covid-19 in-vitro pharmaceutical-technology
May 19, 2020
Sorrento Therapeutics has reported that its Covid-19 therapeutic antibody candidate, STI-1499, can completely block the viral infection in-vitro during preclinical studies.
COVID-19 effect will boost infectious disease drug approvals expresspharma
May 19, 2020
It will present more opportunities to CMOs informs GlobalData, highlighting that in early May, there were 312 novel pipeline drugs for COVID-19, of which 11 were in Phase III trials.
Duke, GenScript, A*STAR Enter COVID-19 Pact contractpharma
May 19, 2020
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimen.
Thermo Fisher Signs COVID-19 Contract with US Govt. contractpharma
May 19, 2020
Will expand capacity in Lenexa, KS with a new $40 million facility dedicated to viral transport media production and quality control.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page